Robotic-Assisted Knee Replacement Designs for Total Knee Replacement
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Zimmer-Biomet Persona Medial Congruent (MC) Bearing Design for total knee replacement?
Research shows that the Persona knee implant system, which includes the Zimmer-Biomet Persona Medial Congruent Bearing, has positive patient-reported outcomes and good implant survivorship up to two years after surgery. Additionally, midterm results indicate that this personalized knee implant offers improved functional outcomes and a higher range of motion five years post-surgery.12345
Is the Persona knee implant system generally safe for use in total knee replacement surgeries?
What makes the Zimmer-Biomet Persona knee replacement designs unique compared to other treatments?
The Zimmer-Biomet Persona knee replacement designs are unique because they offer personalized implant options that aim to better replicate the natural movement of the knee, potentially leading to improved functional outcomes and patient satisfaction. These designs include the Medial Congruent (MC) and Posterior-Stabilized (PS) bearings, which are tailored to enhance the range of motion and overall knee function.12489
What is the purpose of this trial?
A randomized, controlled study comparing two total knee implant devices, Persona medial congruent (MC) vs posterior stabilized (PS). These surgeries will be performed using the ROSA robotic system. Patients will be followed up to 5 years.
Research Team
Vinay Aggarwal, MD
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for adults over 18 who need a knee replacement due to osteoarthritis or inflammatory arthritis and are willing to follow the study's protocol. They must be scheduled for surgery using the ROSA robotic system and have access to a device that works with an Apple Watch and mymobility App.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Total Knee Arthroplasty (TKA) performed using either a posterior stabilized or medial congruent design with the ROSA robotic system
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Zimmer-Biomet Persona Medial Congruent (MC) Bearing Design
- Zimmer-Biomet Persona Posterior-Stabilized (PS) Bearing Design
Zimmer-Biomet Persona Medial Congruent (MC) Bearing Design is already approved in European Union, United States, Canada, Japan for the following indications:
- Total knee replacement for varus osteoarthritis
- Primary total knee arthroplasty
- Total knee replacement for varus osteoarthritis
- Primary total knee arthroplasty
- Total knee replacement for varus osteoarthritis
- Primary total knee arthroplasty
- Total knee replacement for varus osteoarthritis
- Primary total knee arthroplasty
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor